Immunotherapy With Low-Dose IL-2/CD25 Prevents beta-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice. Qureshi FM, Panzer JK, Poder J, Malek TR, et al. Diabetes 2023;72:769-780.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qureshi FM, Panzer JK, Poder J, Malek TR, et al. Immunotherapy With Low-Dose IL-2/CD25 Prevents beta-Cell Dysfunction and Dysglycemia in Prediabetic NOD Mice. Diabetes 2023;72:769-780.
PMID: 36939730